NASDAQ: CMRX
Chimerix Inc Stock Ownership - Who owns Chimerix?

Insider buying vs selling

Have Chimerix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David JakemanVP OF FINANCE AND ACCOUNTING2025-01-302,800$4.10
$11.47kSell
Michael T. AndriolePRESIDENT AND CEO2025-01-302,350$4.10
$9.64kSell
Michelle LaspalutoCHIEF FINANCIAL OFFICER2025-01-301,015$4.11
$4.17kSell
Michael T. AndriolePRESIDENT AND CEO2024-08-081,285$0.83
$1.07kSell
David JakemanVP OF FINANCE AND ACCOUNTING2024-02-142,660$1.04
$2.78kSell
Michael T. AndriolePRESIDENT AND CEO2024-02-141,744$1.04
$1.81kSell
Michelle LaspalutoCHIEF FINANCIAL OFFICER2024-02-141,940$1.04
$2.02kSell

1 of 1

CMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMRX insiders and whales buy or sell their stock.

CMRX Shareholders

What type of owners hold Chimerix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP9.78%8,800,000$34.58MInstitution
Vanguard Group Inc4.81%4,330,398$17.02MInstitution
Sanderling Venture Partners V LP4.79%4,305,046$16.92MInsider
Monaco Asset Management Sam4.69%4,221,574$16.59MInstitution
New Leaf Ventures II LP4.21%3,786,788$14.88MInsider
Cantex Pharmaceuticals Inc3.89%3,500,000$13.76MInsider
Timothy Wollaeger3.70%3,330,102$13.09MInsider
Canaan VII LP2.87%2,584,990$10.16MInsider
Millennium Management LLC2.66%2,395,735$9.42MInstitution
Armistice Capital LLC2.46%2,208,000$8.68MInstitution

1 of 3

CMRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMRX41.26%32.11%Net SellingNet Selling
CDXS46.66%53.34%Net BuyingNet Buying
TNGX54.10%45.90%Net SellingNet Selling
ENGN64.38%35.62%Net Buying
PRME40.26%59.74%Net Buying

Chimerix Stock Ownership FAQ

Who owns Chimerix?

Chimerix (NASDAQ: CMRX) is owned by 41.26% institutional shareholders, 32.11% Chimerix insiders, and 26.63% retail investors. Sanderling Venture Partners V LP is the largest individual Chimerix shareholder, owning 4.31M shares representing 4.79% of the company. Sanderling Venture Partners V LP's Chimerix shares are currently valued at $17.09M.

If you're new to stock investing, here's how to buy Chimerix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.